Vidwan-ID : 589342



  • Dr vijjulatha manga

  • Professor
  • Osmania University
Publications 1994 - 2025

Publications

  • 188
    Journal Articles
  • 1
    Book Chapter
  • 2
    Book
  • 2
    Conference
    Proceedings
  • 5
    Other
  • 12
    Projects
  • 13
  • 8
  • 8
  • 111

Citations / H-Index

1336 Citations
20 h-index
1803 Citations

Altmetrics

1
2
3
32
1

Google Scholar

Co-author Network


Expertise

Applied Chemistry

Actively involved for over 2 decades in developing structure-based molecules as inhibitors of wide-ranging therapeutic targets, spanning from DNA modifying enzymes (PARP), Dihydrofolate reductase, involved in nucleotide biosynthesis, and of signal pathways encompassing, MAP kinases (P38 MAP kinase), JAK-STAT pathway, 5HT7, receptor tyrosine kinases like EGFR and VEGFR, and antiproliferation agents like DNA intercalators and Tubulin polymerase. A deeper examination of the cellular niche of these

Personal Information

Dr vijjulatha manga

Female
Department of Chemistry Osmania University Hyderabad 5-9-9/14 Naubathpahad Opp. Birla Mandir Hyderabad
Hyderabad, Telangana, India - 500004


Experience

  • Professor

    Chemistry

    Osmania University


Qualification

  • Ph.D

    University of Hyderabad

  • M.Sc

    University of Hyderabad

  • B.Sc

    Osmania University


Honours and Awards

2024

Education Stalwart Award

FICCI FLO Hyderabad Chapter.

2023

Women Achiever Award

Indian Institute of Chemical Technology

2023

Vice Chancellors award for Research excellence

Osmania University

Read More
2024

Education Stalwart Award

FICCI FLO Hyderabad Chapter.

2023

Women Achiever Award

Indian Institute of Chemical Technology

2023

Vice Chancellors award for Research excellence

Osmania University

2022

Vice Chancellors award for Research excellence

Osmania University

2022

Women Achiever award in the International Scientist Awards on Engineering, Science and Medicine

VDGood Professional Association.

2019

State award for meritorious Teachers-2019

Government of Telangana

2018

Elected as Fellow of Telangana Academy of Sciences

Telangana Academy of Sciences

Read Less

Doctoral Theses Guided

2024

Computational design, synthesis and biological evaluation of antidepressant molecules

Dr. Nahid Fatima, , MANUU

2023

In silico design, synthesis and biological evaluation of new anticancer agents targeting Pim kinases

Dr. M. Sudhir Reddy , Osmania University

2023

Signaling and metabolism-based Development of Therapeutic Targets for Age Related Pathologies with Focus on Cancer

Dr. Vinutha Kuchana, Osmania University

Read More
2024

Computational design, synthesis and biological evaluation of antidepressant molecules

Dr. Nahid Fatima, , MANUU

2023

In silico design, synthesis and biological evaluation of new anticancer agents targeting Pim kinases

Dr. M. Sudhir Reddy , Osmania University

2023

Signaling and metabolism-based Development of Therapeutic Targets for Age Related Pathologies with Focus on Cancer

Dr. Vinutha Kuchana, Osmania University

2021

Computational design, synthesis and biological evaluation of new chloroquinoline and 2,4,5-triaryl imidazole derivatives

Dr. Janaiah Chevula , Osmania University

2020

Insilico strategies in developing new inhibitors against molecular targets in HIV and Mycobacterium tuberculosis

Dr. Rama Krishna Munnaluri , Osmania University

2019

In Silico Design and Analysis of 1,3,4-Oxadiazole based cyclic peptides

Dr.SaiKiran Reddy , Osmania University

2019

Computer Aided Drug Design, Synthesis and Biological Evaluation of Antibacterial Agents against Wild and Resistant Strains of Staphylococcus Aureus

Dr. Srilata Ballu , Osmania University

2018

Design and Synthesis of Metastasis, Angiogenesis and Vasculogenesis Inhibitors

Dr. Raju Bathini , Osmania University

2018

Computational Design, Synthesis and Biological Evaluation of Novel Anticancer Agents Targeting JAKSTAT Signaling Pathway

Dr. Ramesh Iteboina , Osmania University

2017

Identification and Synthesis of Antiviral Drugs, using Drug Design Techniques

Dr. V. Radhika, Osmania University

2016

In Silico Drug Design and Synthesis of Potential Novel Antimalarial Agents

Dr. B.Saikrishna , Osmania University

2016

Design December, 2014of inhibitors for cognitive disorder using computational studies

Dr. Mohan babu jatavath , Osmania University

2016

Computational Design and Synthesis of Poly (ADP-Ribose) polymerase-1 (PARP-1) Inhibitors

Dr. Sabiha Fathima , Osmania University

2014

Computational Design, Synthesis and Activity studies of DNA Synthesis and Unzipping Inhibitors

Dr. K. Meena Kumari, Osmania University

2013

Computer Aided Drug Design and Synthesis of DHFR Inhibitors

Dr. L. Yamini, Osmania University

2012

Design and synthesis of highly potent molecules for inhibition of AIDS

Dr. S. Sree Kanth, Osmania University

Read Less

Membership In Professional Bodies

2021

Indian Women Scientists Association

Life Member

2020

Royal Society of Chemistry

Life Member

2018

Indian Council of Chemists

Life Member

Read More
2021

Indian Women Scientists Association

Life Member

2020

Royal Society of Chemistry

Life Member

2018

Indian Council of Chemists

Life Member

2014

Telangana Academy of Sciences

Life Member

2010

American Chemical Society

Life Member

2004

Indian Science Congress

Life Member

Read Less

Membership In Committees

2023

Telangana Academy of Sciences

Executive council member

2023

Telangana Academy of Sciences

Executive council member

Read Less

Research Projects

Computational Analysis of Mutational Effects on HIV-1 Antiretroviral Therapy and Target Oriented Synthesis of Potential Lead molecules

Funding Agency : SERB

Development of molecular based novel inhibitors on signaling with focus on PI3K-AKT-mTOR pathway

Funding Agency : CSIR

Synthesis and anti-viral evaluation of newly designed nucleoside analogs beyond repurposing through revamping against emerging corona virus 2019 nCoV/SARS-CoV-2 by computational protocols

Funding Agency : • DBT-BIRAC COVID-19 Research Consortium

Read More

Computational Analysis of Mutational Effects on HIV-1 Antiretroviral Therapy and Target Oriented Synthesis of Potential Lead molecules

Funding Agency : SERB

Development of molecular based novel inhibitors on signaling with focus on PI3K-AKT-mTOR pathway

Funding Agency : CSIR

Synthesis and anti-viral evaluation of newly designed nucleoside analogs beyond repurposing through revamping against emerging corona virus 2019 nCoV/SARS-CoV-2 by computational protocols

Funding Agency : • DBT-BIRAC COVID-19 Research Consortium

Signaling and Metabolism based Development of Therapeutic Targets for Age Related Pathologies with Focus on Cancer

Funding Agency : DST PURSE

In Silico Designing of Aldose Reductase Inhibitors for the Treatment of Diabetic Retinopathy

Funding Agency : UGC FAR

Design, synthesis and activity studies of novel kinase inhibitors targeting signalling cascade in cell proliferation

Funding Agency : UGC FAR

Computational design and synthesis of small molecule inhibitors targeting non-trivial proteins of HIV-1

Funding Agency : SERB

Combining Multiple receptor conformation docking and 3D QSAR protocols for identification and design of Novel Cycloguanil derivatives as Plasmodium falciparum DHFR inhibitors

Funding Agency : UGC

Diversity oriented privileged structures as Anti-cancer and Anti-malarial drug molecules

Funding Agency : UGC FAR

Computational Design, Docking, QSAR, Synthetic and Activity Studies on Thymidylate Synthase (Human and E.coli)

Funding Agency : CSIR

Computational Design and Synthesis of Novel Cyclic Urea as HIV – 1 Protease Inhibitors

Funding Agency : DST

Computational Design, Synthesis and Activity Studies of Novel High Affinity Human Dihydrofolate Reductase (DHFR) Inhibitors.

Funding Agency : UGC

Read Less

Patents




Read More






Read Less